ALT · Altimmune, Inc.
$2.81
-0.06 (-2.09%)
At close · Jul 20
Market Cap
$546.47M
Shares
194.47M
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
Fiscal 2020
| Executive | Role | Total |
|---|---|---|
| Vipin K. Garg | CEO | $1,434,401 |
| Scott Harris | Chief Medical Officer | $670,183 |
| Scot Roberts | Chief Scientific Officer | $627,974 |
| William Brown | CFO | $622,106 |
| Sybil Tasker | Former Chief Medical Officer | — |
Fiscal 2019
| Executive | Role | Total |
|---|---|---|
| Vipin K. Garg | CEO | $814,647 |
| William Brown | CFO | $624,347 |
| Scot Roberts | Chief Scientific Officer | $448,261 |
| Scott Harris | Chief Medical Officer | $382,908 |
| Sybil Tasker | Former Chief Medical Officer | $356,515 |
| Elizabeth A. Czerepak | CFO | — |
| William Enright | CEO | — |
Fiscal 2018
| Executive | Role | Total |
|---|---|---|
| Vipin K. Garg | CEO | $2,189,964 |
| William Enright | CEO | $637,706 |
| Sybil Tasker | Former Chief Medical Officer | $546,331 |
| William Brown | CFO | $216,000 |
| Elizabeth A. Czerepak | CFO | $131,999 |
| Scott Harris | Chief Medical Officer | — |
Key facts
CIK
1326190
CUSIP
02155H200
13F (30d)
15 filings
15 filers
Visit website
Investor relations